Whitehawk Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
Stocks in this Quantisnow insightHealth Care
Historical context for WHWK
Across the 14 sessions after earlier WHWK headlines, the stock closed higher 5 times and lower 9 times, with a median move of 2.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | WHWK | SPY |
|---|---|---|---|
| Apr 20, 2026 | Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026 | +2.9% | -0.2% |
| Apr 17, 2026 | Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series | -2.8% | +1.2% |
| Apr 10, 2026 | Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026 | -4.5% | -0.1% |
| Mar 18, 2026 | Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 | -3.5% | -1.4% |
| Mar 12, 2026 | Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights | -2.7% | -1.5% |
| Feb 26, 2026 | Whitehawk Therapeutics to Participate in Upcoming Investor Conferences | -1.5% | -0.6% |
Keep researching WHWK
Quantisnow market dataNASDAQ
WHWK
Whitehawk Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for WHWK
Full WHWK profile on Quantisnow Follow WHWK and get a push notification the moment its next story breaks.